whether they have any difficulties with application, cosmetic acceptability or tolerability and offer an alternative formulation if appropriate possible reasons for non-adherence Arrange a review appointment after starting a new topical treatment after 4 weeks in adults Phototherapy is available in specialist centres under the supervision of a dermatologist. UVB radiation is usually effective for chronic stable psoriasis and for guttate psoriasis Acitretin (Neotigason®), an oral retinoid (vitamin A derivate), is available as a RED list medication in Northern Ireland for psoriasis. It is to be prescribed and supplied solely within the secondary care environment. Identification of co-morbidities Discuss risk factors for cardiovascular co-morbidities with people who have any type of psoriasis (and their families or carers where appropriate) and give lifestyle advice as appropriate In patients with severe psoriasis, offer a cardiovascular risk assessment at presentation using a validated risk assessment tool. Repeat every 5 years (or more frequently if indicated) Psoriasis of any type, especially if severe, is a risk factor for venous thromboembolism in adults. This risk should be explained to adults with any type of psoriasis and advice offered on how to minimise and manage the risk in line with Venous Thromboembolism: reducing the risk Topical preparations for psoriasis Trunk and limbs Vitamin D and analogues (1st line agents) 1st choice Calcipotriol 50 Dose: micrograms/g; Apply 1-2 times daily; max (Dovonex®) 100g per week
whether they have any difficulties with application, cosmetic acceptability or tolerability and offer an alternative formulation if appropriate possible reasons for non-adherence Arrange a review appointment after starting a new topical treatment after 4 weeks in adults Phototherapy is available in specialist centres under the supervision of a dermatologist. UVB radiation is usually effective for chronic stable psoriasis and for guttate psoriasis Acitretin (Neotigason®), an oral retinoid (vitamin A derivate), is available as a RED list medication in Northern Ireland for psoriasis. It is to be prescribed and supplied solely within the secondary care environment. Identification of co-morbidities Discuss risk factors for cardiovascular co-morbidities with people who have any type of psoriasis (and their families or carers where appropriate) and give lifestyle advice as appropriate In patients with severe psoriasis, offer a cardiovascular risk assessment at presentation using a validated risk assessment tool. Repeat every 5 years (or more frequently if indicated) Psoriasis of any type, especially if severe, is a risk factor for venous thromboembolism in adults. This risk should be explained to adults with any type of psoriasis and advice offered on how to minimise and manage the risk in line with Venous Thromboembolism: reducing the risk Topical preparations for psoriasis Trunk and limbs Vitamin D and analogues (1st line agents) 1st choice Calcipotriol 50 micrograms/g; (Dovonex®) Dose: Apply 1-2 times daily; max 100g per week
NI%20Formulary%20draft%20for%20consultation.docx